Form D · Biotechnology
Isoflux Inc
Rochester, NY · CIK 0001470623
Offering snapshot reported Aug 19, 2009 · SEC filing
- Reported sold
- $520K Offering amount: $825K
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Aug 18, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2009 | Initial | $520,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-133766
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Isoflux Incorporated | None |
Source: Form D, filed Aug 19, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jose Coronas | Director |
| David Glocker | Director |
| Miller Joseph | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10 Vantage Point Drive Suite 4
Rochester, NY, 14624
Rochester, NY, 14624